Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 18 | 2018 | 198 | 4.270 |
Why?
|
| Herniorrhaphy | 7 | 2016 | 38 | 2.940 |
Why?
|
| Postoperative Complications | 16 | 2018 | 934 | 2.680 |
Why?
|
| Cholecystectomy, Laparoscopic | 5 | 2018 | 36 | 1.970 |
Why?
|
| Quality Improvement | 4 | 2014 | 161 | 1.650 |
Why?
|
| Colectomy | 4 | 2016 | 23 | 1.560 |
Why?
|
| General Surgery | 7 | 2015 | 52 | 1.430 |
Why?
|
| Hernia, Ventral | 3 | 2016 | 22 | 1.410 |
Why?
|
| Surgical Mesh | 3 | 2014 | 26 | 1.310 |
Why?
|
| Hernia, Inguinal | 3 | 2016 | 23 | 1.110 |
Why?
|
| Hernia, Hiatal | 4 | 2014 | 13 | 1.110 |
Why?
|
| Gastrectomy | 2 | 2016 | 31 | 1.020 |
Why?
|
| Carcinoma | 2 | 2016 | 70 | 1.010 |
Why?
|
| Stomach Neoplasms | 2 | 2016 | 35 | 1.000 |
Why?
|
| Middle Aged | 29 | 2018 | 9306 | 1.000 |
Why?
|
| Smoking | 2 | 2016 | 179 | 0.980 |
Why?
|
| Male | 37 | 2018 | 15367 | 0.950 |
Why?
|
| Treatment Outcome | 20 | 2016 | 3619 | 0.940 |
Why?
|
| Female | 37 | 2018 | 15793 | 0.940 |
Why?
|
| Adult | 25 | 2018 | 8152 | 0.870 |
Why?
|
| Humans | 42 | 2018 | 28462 | 0.770 |
Why?
|
| Colonic Neoplasms | 3 | 2016 | 61 | 0.720 |
Why?
|
| Educational Measurement | 3 | 2015 | 60 | 0.720 |
Why?
|
| Retrospective Studies | 20 | 2018 | 3612 | 0.690 |
Why?
|
| Internship and Residency | 4 | 2015 | 217 | 0.670 |
Why?
|
| Databases, Factual | 6 | 2016 | 358 | 0.660 |
Why?
|
| Pneumonia | 2 | 2016 | 77 | 0.630 |
Why?
|
| Logistic Models | 5 | 2016 | 397 | 0.580 |
Why?
|
| Fundoplication | 3 | 2013 | 22 | 0.580 |
Why?
|
| Cholecystectomy | 2 | 2018 | 19 | 0.580 |
Why?
|
| Aged | 17 | 2018 | 9339 | 0.550 |
Why?
|
| Splenic Neoplasms | 1 | 2016 | 4 | 0.540 |
Why?
|
| Splenectomy | 1 | 2016 | 7 | 0.540 |
Why?
|
| Superior Mesenteric Artery Syndrome | 1 | 2016 | 3 | 0.540 |
Why?
|
| Duodenostomy | 1 | 2016 | 3 | 0.540 |
Why?
|
| Jejunostomy | 1 | 2016 | 9 | 0.530 |
Why?
|
| Cadherins | 1 | 2016 | 36 | 0.530 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2016 | 8 | 0.520 |
Why?
|
| Enterostomy | 1 | 2016 | 6 | 0.520 |
Why?
|
| Neoplasms, Second Primary | 1 | 2016 | 40 | 0.520 |
Why?
|
| Barrett Esophagus | 1 | 2015 | 16 | 0.510 |
Why?
|
| Precancerous Conditions | 1 | 2015 | 25 | 0.510 |
Why?
|
| End Stage Liver Disease | 1 | 2015 | 13 | 0.500 |
Why?
|
| Certification | 1 | 2015 | 49 | 0.490 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 70 | 0.490 |
Why?
|
| Gallbladder Neoplasms | 1 | 2015 | 5 | 0.490 |
Why?
|
| Gastroscopy | 1 | 2015 | 9 | 0.480 |
Why?
|
| Gastrostomy | 1 | 2015 | 10 | 0.480 |
Why?
|
| Appendectomy | 1 | 2014 | 16 | 0.480 |
Why?
|
| Appendicitis | 1 | 2014 | 18 | 0.470 |
Why?
|
| Mutation | 1 | 2016 | 349 | 0.470 |
Why?
|
| Survival Rate | 5 | 2015 | 356 | 0.460 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 122 | 0.460 |
Why?
|
| Colon, Sigmoid | 1 | 2014 | 18 | 0.460 |
Why?
|
| Patient Safety | 1 | 2015 | 54 | 0.460 |
Why?
|
| Scrotum | 1 | 2014 | 14 | 0.460 |
Why?
|
| United States | 8 | 2016 | 2185 | 0.460 |
Why?
|
| Credentialing | 1 | 2014 | 8 | 0.450 |
Why?
|
| Biliary Dyskinesia | 1 | 2013 | 3 | 0.450 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2015 | 75 | 0.450 |
Why?
|
| Gallstones | 1 | 2014 | 10 | 0.450 |
Why?
|
| Intestine, Small | 1 | 2014 | 34 | 0.440 |
Why?
|
| Elective Surgical Procedures | 1 | 2014 | 39 | 0.440 |
Why?
|
| Gastroplasty | 4 | 2014 | 28 | 0.430 |
Why?
|
| Follow-Up Studies | 7 | 2015 | 1868 | 0.430 |
Why?
|
| Gallbladder Diseases | 1 | 2013 | 5 | 0.430 |
Why?
|
| Head and Neck Neoplasms | 1 | 2015 | 151 | 0.420 |
Why?
|
| Abdominal Wall | 1 | 2013 | 7 | 0.420 |
Why?
|
| Clinical Competence | 3 | 2015 | 247 | 0.410 |
Why?
|
| Education, Medical, Graduate | 1 | 2013 | 77 | 0.400 |
Why?
|
| Sepsis | 1 | 2014 | 144 | 0.400 |
Why?
|
| Patient Satisfaction | 2 | 2013 | 329 | 0.390 |
Why?
|
| Esophageal Achalasia | 1 | 2012 | 18 | 0.390 |
Why?
|
| Physicians | 1 | 2014 | 121 | 0.390 |
Why?
|
| Operative Time | 5 | 2018 | 93 | 0.380 |
Why?
|
| Risk Factors | 7 | 2016 | 2421 | 0.380 |
Why?
|
| Esophagus | 1 | 2012 | 65 | 0.370 |
Why?
|
| Heart Transplantation | 3 | 2015 | 30 | 0.340 |
Why?
|
| Length of Stay | 4 | 2018 | 328 | 0.330 |
Why?
|
| Obesity, Morbid | 3 | 2014 | 104 | 0.290 |
Why?
|
| Image-Guided Biopsy | 2 | 2018 | 39 | 0.260 |
Why?
|
| Clinical Clerkship | 3 | 2015 | 30 | 0.260 |
Why?
|
| Graft Rejection | 3 | 2015 | 71 | 0.260 |
Why?
|
| Surgical Wound Infection | 2 | 2016 | 88 | 0.230 |
Why?
|
| Comorbidity | 2 | 2016 | 502 | 0.210 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 4904 | 0.210 |
Why?
|
| Students, Medical | 2 | 2013 | 49 | 0.210 |
Why?
|
| Reoperation | 4 | 2016 | 917 | 0.210 |
Why?
|
| Recurrence | 2 | 2014 | 320 | 0.210 |
Why?
|
| Surveys and Questionnaires | 3 | 2015 | 1216 | 0.190 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 494 | 0.160 |
Why?
|
| Cholecystitis, Acute | 1 | 2018 | 8 | 0.150 |
Why?
|
| Survival Analysis | 2 | 2015 | 267 | 0.150 |
Why?
|
| Weight Loss | 3 | 2014 | 128 | 0.150 |
Why?
|
| Ultrasonography, Interventional | 2 | 2015 | 76 | 0.150 |
Why?
|
| Lymph Nodes | 1 | 2018 | 70 | 0.140 |
Why?
|
| Tobacco Smoking | 1 | 2016 | 5 | 0.140 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2016 | 6 | 0.140 |
Why?
|
| Angina Pectoris | 1 | 2016 | 16 | 0.140 |
Why?
|
| Age Factors | 2 | 2016 | 793 | 0.130 |
Why?
|
| Time Factors | 3 | 2015 | 1497 | 0.130 |
Why?
|
| Antigens, CD | 1 | 2016 | 53 | 0.130 |
Why?
|
| Anastomosis, Surgical | 1 | 2016 | 30 | 0.130 |
Why?
|
| Cholangiography | 1 | 2015 | 12 | 0.130 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 52 | 0.130 |
Why?
|
| Hernia, Umbilical | 1 | 2015 | 3 | 0.130 |
Why?
|
| Prospective Studies | 3 | 2018 | 1810 | 0.120 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 334 | 0.120 |
Why?
|
| Cohort Studies | 3 | 2015 | 1948 | 0.120 |
Why?
|
| Confidence Intervals | 1 | 2015 | 97 | 0.120 |
Why?
|
| Writing | 1 | 2015 | 21 | 0.120 |
Why?
|
| Intestines | 1 | 2016 | 102 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 137 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2015 | 45 | 0.120 |
Why?
|
| Genetic Markers | 1 | 2015 | 36 | 0.120 |
Why?
|
| Lymph Node Excision | 1 | 2015 | 27 | 0.120 |
Why?
|
| Continuity of Patient Care | 1 | 2015 | 23 | 0.120 |
Why?
|
| Abdominal Neoplasms | 1 | 2014 | 15 | 0.120 |
Why?
|
| Morbidity | 1 | 2014 | 58 | 0.120 |
Why?
|
| Sex Factors | 1 | 2016 | 480 | 0.120 |
Why?
|
| Lymphoma | 1 | 2014 | 38 | 0.120 |
Why?
|
| Insurance, Health | 1 | 2014 | 23 | 0.120 |
Why?
|
| Odds Ratio | 1 | 2015 | 274 | 0.120 |
Why?
|
| Hypertension | 1 | 2016 | 226 | 0.120 |
Why?
|
| Myocardium | 1 | 2015 | 103 | 0.110 |
Why?
|
| Radiography, Abdominal | 1 | 2014 | 5 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 140 | 0.110 |
Why?
|
| Biopsy | 1 | 2015 | 221 | 0.110 |
Why?
|
| Hemobilia | 1 | 2014 | 2 | 0.110 |
Why?
|
| Respiratory Tract Fistula | 1 | 2014 | 2 | 0.110 |
Why?
|
| Mirizzi Syndrome | 1 | 2014 | 2 | 0.110 |
Why?
|
| Hepatectomy | 1 | 2015 | 64 | 0.110 |
Why?
|
| Primary Graft Dysfunction | 1 | 2014 | 5 | 0.110 |
Why?
|
| Cutaneous Fistula | 1 | 2014 | 4 | 0.110 |
Why?
|
| Duodenal Diseases | 1 | 2014 | 3 | 0.110 |
Why?
|
| Ileus | 1 | 2014 | 4 | 0.110 |
Why?
|
| Urinary Fistula | 1 | 2014 | 4 | 0.110 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 157 | 0.110 |
Why?
|
| Intestinal Fistula | 1 | 2014 | 5 | 0.110 |
Why?
|
| Vascular Fistula | 1 | 2014 | 4 | 0.110 |
Why?
|
| Biliary Fistula | 1 | 2014 | 7 | 0.110 |
Why?
|
| Colonic Diseases | 1 | 2014 | 10 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 992 | 0.110 |
Why?
|
| Blood Transfusion | 1 | 2014 | 66 | 0.110 |
Why?
|
| Hospital Mortality | 1 | 2015 | 146 | 0.110 |
Why?
|
| Illinois | 1 | 2014 | 247 | 0.110 |
Why?
|
| Graft Survival | 1 | 2014 | 102 | 0.110 |
Why?
|
| Specialties, Surgical | 1 | 2013 | 3 | 0.110 |
Why?
|
| Prosthesis Implantation | 1 | 2013 | 31 | 0.110 |
Why?
|
| Surgical Procedures, Operative | 1 | 2013 | 27 | 0.110 |
Why?
|
| Animals, Laboratory | 1 | 2013 | 3 | 0.110 |
Why?
|
| Tissue Donors | 1 | 2014 | 79 | 0.110 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 372 | 0.110 |
Why?
|
| Duodenal Neoplasms | 1 | 2013 | 6 | 0.110 |
Why?
|
| Wound Healing | 1 | 2014 | 160 | 0.110 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2013 | 33 | 0.110 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2013 | 15 | 0.110 |
Why?
|
| Heart Diseases | 1 | 2014 | 68 | 0.110 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2014 | 318 | 0.110 |
Why?
|
| Education, Medical | 1 | 2013 | 41 | 0.110 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2013 | 42 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2015 | 676 | 0.100 |
Why?
|
| Radiography | 1 | 2014 | 651 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2013 | 98 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2013 | 600 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2018 | 440 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 772 | 0.080 |
Why?
|
| Gastroesophageal Reflux | 1 | 2009 | 27 | 0.080 |
Why?
|
| Actinomycetales | 1 | 2004 | 1 | 0.060 |
Why?
|
| Erythromycin | 1 | 2004 | 3 | 0.060 |
Why?
|
| Genes, Bacterial | 1 | 2004 | 4 | 0.060 |
Why?
|
| Young Adult | 2 | 2018 | 2100 | 0.040 |
Why?
|
| Patient Admission | 1 | 2018 | 26 | 0.040 |
Why?
|
| Blood Loss, Surgical | 1 | 2018 | 59 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2018 | 233 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2018 | 295 | 0.030 |
Why?
|
| Algorithms | 1 | 2018 | 378 | 0.030 |
Why?
|
| Job Application | 1 | 2015 | 8 | 0.030 |
Why?
|
| Los Angeles | 1 | 2015 | 10 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 58 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 177 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 179 | 0.030 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2014 | 1 | 0.030 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2014 | 8 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2014 | 23 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 117 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 138 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2014 | 81 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 78 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 371 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 279 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2013 | 135 | 0.030 |
Why?
|
| Anxiety | 1 | 2013 | 161 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2012 | 140 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 824 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2013 | 243 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2012 | 466 | 0.020 |
Why?
|
| History, 18th Century | 1 | 2009 | 6 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2009 | 163 | 0.020 |
Why?
|
| Animals | 1 | 2013 | 3798 | 0.020 |
Why?
|
| Glucosyltransferases | 1 | 2004 | 1 | 0.010 |
Why?
|
| Saccharopolyspora | 1 | 2004 | 1 | 0.010 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2004 | 1 | 0.010 |
Why?
|
| Fatty Acid Synthases | 1 | 2004 | 1 | 0.010 |
Why?
|
| Thiolester Hydrolases | 1 | 2004 | 3 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 2004 | 3 | 0.010 |
Why?
|
| Sequence Homology | 1 | 2004 | 3 | 0.010 |
Why?
|
| Multigene Family | 1 | 2004 | 9 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 2004 | 10 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 27 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2004 | 41 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2004 | 44 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 57 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2004 | 37 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 190 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2004 | 77 | 0.010 |
Why?
|